Sanofi - SWOT, Strategy and Corporate Finance Report
Published: July 2013 · Publisher: MarketLine
Sanofi - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
Sanofi - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.
Features:
- Detailed information on Sanofi required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanofi in the form of a SWOT analysis
- An in-depth view of the business model of Sanofi including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Sanofi
- Intelligence on Sanofinv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanofi, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Sanofi (or 'the group') is a France-based international pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. It offers biopharmaceuticals, human vaccines and animal and consumer health products. The group operates in more than 100 countries. It is headquartered in Paris, France, and employed 111,974 people as of December 31, 2012. The company recorded revenues of E34,947 million ($44,934.9 million*) during the financial year ended December 2012 (FY2012), an increase of 4.7% over FY2011. The operating profit of the company was E6,337 million ($8,148.1 million*) in FY2012, an increase of 10.6% over FY2011. The net profit was E4,967 million ($6,386.6 million*) in FY2012, a decrease of 12.8% over FY2011. *Calculated using a constant conversion rate of E1 = $1.2858 for the year ended December 31, 2012.
Reasons to Purchase:
- Gain understanding of Sanofi and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Sanofi as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Sanofi’s business structure, strategy and prospects
Features:
- Detailed information on Sanofi required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanofi in the form of a SWOT analysis
- An in-depth view of the business model of Sanofi including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Sanofi
- Intelligence on Sanofinv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanofi, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Sanofi (or 'the group') is a France-based international pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. It offers biopharmaceuticals, human vaccines and animal and consumer health products. The group operates in more than 100 countries. It is headquartered in Paris, France, and employed 111,974 people as of December 31, 2012. The company recorded revenues of E34,947 million ($44,934.9 million*) during the financial year ended December 2012 (FY2012), an increase of 4.7% over FY2011. The operating profit of the company was E6,337 million ($8,148.1 million*) in FY2012, an increase of 10.6% over FY2011. The net profit was E4,967 million ($6,386.6 million*) in FY2012, a decrease of 12.8% over FY2011. *Calculated using a constant conversion rate of E1 = $1.2858 for the year ended December 31, 2012.
Reasons to Purchase:
- Gain understanding of Sanofi and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Sanofi as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Sanofi’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Sanofi: Company Overview
Sanofi: Overview and Key Facts
Sanofi: Overview
Sanofi: Key Facts
Sanofi: Key Employees
Sanofi: Key Employee Biographies
Sanofi: Major Products and Services
Sanofi: Company History
Sanofi: Management Statement
Sanofi: Locations and Subsidiaries
Sanofi: Key Competitors
Sanofi: Company Analysis
Sanofi: Business Description
Sanofi: SWOT Analysis
Sanofi: SWOT Overview
Sanofi: Strengths
Sanofi: Weaknesses
Sanofi: Opportunities
Sanofi: Threats
Sanofi: Financial Analysis
Sanofi: Financial Overview
Sanofi: Five Year Company Financials
Sanofi: Key Income Statement Data
Sanofi: Key Balance Sheet Data
Sanofi: Key Cash Flow Data
Sanofi: Key Market Data
Sanofi: Valuation Ratios
Sanofi: Profitability Ratios
Sanofi: Management Efficiency Ratios
Sanofi: Financial Strength Ratios
Sanofi: Operational Efficiency Ratios
Sanofi: Others
Sanofi: Corporate Financial Deals Activity
Sanofi: Financial Deals Overview
Sanofi: Targets and Partners
Sanofi: Top Deals 2009 - 2013YTD*
Sanofi: Advisors
Sanofi: Top Legal Advisors
Sanofi: Top Financial Advisors
Sanofi: Mergers and Acquisitions
Sanofi: Corporate Venturing
Sanofi: Partnership
Sanofi: Divestments
Sanofi: Recent Developments
Sanofi: News and Events Summary
Sanofi: Contracts
Sanofi: Corporate Governance
Sanofi: Financial Deals
Sanofi: Financial Performance
Sanofi: Regulatory and Legal Events
Sanofi: Research & Development
Sanofi: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Sanofi: Key Facts
Table 2: Sanofi: Key Employees
Table 4: Sanofi: Key Competitors
Table 5: Sanofi: Key Income Statement Data
Table 6: Sanofi: Key Balance Sheet Data
Table 7: Sanofi: Key Cash Flow Data
Table 8: Sanofi: Key Market Data
Table 9: Sanofi: Key Growth Ratios
Table 10: Sanofi: Valuation Ratios
Table 11: Sanofi: Profitability Ratios
Table 12: Sanofi: Management Efficiency Ratios
Table 13: Sanofi: Financial Strength Ratios
Table 14: Sanofi: Operational Efficiency Ratios
Table 15: Sanofi: Others
Table 16: Sanofi: Deal Activity by Deal Type - Volume (TTM*)
Table 17: Sanofi: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 18: Sanofi: M&A Average Deal Size - Value (US$m)
Table 19: Sanofi: Targets and Partners
Table 20: Sanofi: Top Deals 2009 - 2013YTD*
Table 21: Sanofi: Legal Advisor Ranking by Value (US$m)
Table 22: Sanofi: Financial Advisor Ranking by Value (US$m)
Table 23: Sanofi: M&A Volume and Value Trend (2009 - YTD*2013)
Table 24: Sanofi: M&A Activity by Geography (2009 - YTD*2013)
Table 25: Sanofi: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 26: Sanofi: Corporate Venturing by Geography (2009 - YTD*2013)
Table 27: Sanofi: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 28: Sanofi: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 29: Sanofi: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 30: Sanofi: Divestments by Geography (2009 - YTD*2013)
Table 31: Sanofi: News and Events Summary
Table 32: Sanofi: Contracts
Table 33: Sanofi: Corporate Governance
Table 34: Sanofi: Financial Deals
Table 35: Sanofi: Financial Performance
Table 36: Sanofi: Regulatory and Legal Events
Table 37: Sanofi: Research & Development
Table 38: Sanofi: Strategy and Operations
List of Figures
Figure 1: Sanofi: Revenue to Net Income (2007-2011)
Figure 2: Sanofi: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: Sanofi: Current Assets to Current Liabilities (2007-2011)
Figure 4: Sanofi: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: Sanofi: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: Sanofi: Net Change in Cash (2007-2011)
Figure 7: Sanofi: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: Sanofi: Enterprise Value (2007-2011)
Figure 9: Sanofi: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Sanofi: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 11: Sanofi: M&A Average Deal Size - Value (US$m)
Figure 12: Sanofi: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 13: Sanofi: M&A Activity by Geography (2009 - YTD*2013)
Figure 14: Sanofi: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 15: Sanofi: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 16: Sanofi: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 17: Sanofi: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 18: Sanofi: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 19: Sanofi: Divestments by Geography (2009 - YTD*2013)
Sanofi: Company Overview
Sanofi: Overview and Key Facts
Sanofi: Overview
Sanofi: Key Facts
Sanofi: Key Employees
Sanofi: Key Employee Biographies
Sanofi: Major Products and Services
Sanofi: Company History
Sanofi: Management Statement
Sanofi: Locations and Subsidiaries
Sanofi: Key Competitors
Sanofi: Company Analysis
Sanofi: Business Description
Sanofi: SWOT Analysis
Sanofi: SWOT Overview
Sanofi: Strengths
Sanofi: Weaknesses
Sanofi: Opportunities
Sanofi: Threats
Sanofi: Financial Analysis
Sanofi: Financial Overview
Sanofi: Five Year Company Financials
Sanofi: Key Income Statement Data
Sanofi: Key Balance Sheet Data
Sanofi: Key Cash Flow Data
Sanofi: Key Market Data
Sanofi: Valuation Ratios
Sanofi: Profitability Ratios
Sanofi: Management Efficiency Ratios
Sanofi: Financial Strength Ratios
Sanofi: Operational Efficiency Ratios
Sanofi: Others
Sanofi: Corporate Financial Deals Activity
Sanofi: Financial Deals Overview
Sanofi: Targets and Partners
Sanofi: Top Deals 2009 - 2013YTD*
Sanofi: Advisors
Sanofi: Top Legal Advisors
Sanofi: Top Financial Advisors
Sanofi: Mergers and Acquisitions
Sanofi: Corporate Venturing
Sanofi: Partnership
Sanofi: Divestments
Sanofi: Recent Developments
Sanofi: News and Events Summary
Sanofi: Contracts
Sanofi: Corporate Governance
Sanofi: Financial Deals
Sanofi: Financial Performance
Sanofi: Regulatory and Legal Events
Sanofi: Research & Development
Sanofi: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Sanofi: Key Facts
Table 2: Sanofi: Key Employees
Table 4: Sanofi: Key Competitors
Table 5: Sanofi: Key Income Statement Data
Table 6: Sanofi: Key Balance Sheet Data
Table 7: Sanofi: Key Cash Flow Data
Table 8: Sanofi: Key Market Data
Table 9: Sanofi: Key Growth Ratios
Table 10: Sanofi: Valuation Ratios
Table 11: Sanofi: Profitability Ratios
Table 12: Sanofi: Management Efficiency Ratios
Table 13: Sanofi: Financial Strength Ratios
Table 14: Sanofi: Operational Efficiency Ratios
Table 15: Sanofi: Others
Table 16: Sanofi: Deal Activity by Deal Type - Volume (TTM*)
Table 17: Sanofi: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 18: Sanofi: M&A Average Deal Size - Value (US$m)
Table 19: Sanofi: Targets and Partners
Table 20: Sanofi: Top Deals 2009 - 2013YTD*
Table 21: Sanofi: Legal Advisor Ranking by Value (US$m)
Table 22: Sanofi: Financial Advisor Ranking by Value (US$m)
Table 23: Sanofi: M&A Volume and Value Trend (2009 - YTD*2013)
Table 24: Sanofi: M&A Activity by Geography (2009 - YTD*2013)
Table 25: Sanofi: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 26: Sanofi: Corporate Venturing by Geography (2009 - YTD*2013)
Table 27: Sanofi: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 28: Sanofi: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 29: Sanofi: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 30: Sanofi: Divestments by Geography (2009 - YTD*2013)
Table 31: Sanofi: News and Events Summary
Table 32: Sanofi: Contracts
Table 33: Sanofi: Corporate Governance
Table 34: Sanofi: Financial Deals
Table 35: Sanofi: Financial Performance
Table 36: Sanofi: Regulatory and Legal Events
Table 37: Sanofi: Research & Development
Table 38: Sanofi: Strategy and Operations
List of Figures
Figure 1: Sanofi: Revenue to Net Income (2007-2011)
Figure 2: Sanofi: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: Sanofi: Current Assets to Current Liabilities (2007-2011)
Figure 4: Sanofi: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: Sanofi: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: Sanofi: Net Change in Cash (2007-2011)
Figure 7: Sanofi: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: Sanofi: Enterprise Value (2007-2011)
Figure 9: Sanofi: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Sanofi: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 11: Sanofi: M&A Average Deal Size - Value (US$m)
Figure 12: Sanofi: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 13: Sanofi: M&A Activity by Geography (2009 - YTD*2013)
Figure 14: Sanofi: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 15: Sanofi: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 16: Sanofi: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 17: Sanofi: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 18: Sanofi: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 19: Sanofi: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.